Compound for modulating rlr, tlr, oas and/or oncostatin m pathways, use thereof for preparing a medicine, composition, method for modulating said pathways and method of treatment


Abstract
The invention falls within the fields of pharmaceutical sciences, immunology and methods of treatment of cancer Methods. More specifically, the invention relates to a compound for modulating one or more innate immune pathways selected from RLR, TLR, OAS and/or oncostatin M, said compound being amblyomin-X or peptides derived from amblyomin-X. Use of said compound for preparing medicines; a pharmaceutical composition comprising said compound, a method for modulating said pathways in vitro and a method of treatment are also described.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/4323
Issue Date
2022

Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.